semaglutide clinical trials near me HUGE news in the GLP-1 space! Orforglipron has outperformed oral in the ACHIEVE-3 trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ A phase 2 clinical trial

The largest psychiatric safety meta-analysis to date found that GLP-1 medications were not associated with increased risk of serious psychiatric adverse events overall ( Pierret et al., JAMA Psychiatry, 2025 ), and a post-hoc analysis of the major semaglutide weight management trials found no differences in depression, suicidal ideation, or suicidal behavior compared to placebo ( Wadden et al., JAMA Internal Medicine, 2024 )

Renal dipeptidase has been mapped to human chromosome 16 at q24 [50]

Haemodynamic factors, RAS overactivation and hypertension are central to CKD development and progression in diabetes

That warning should change how people interpret online offers